Hospital
Latrobe Area Hospital, INC.
Latrobe Area Hospital, INC. was paid $4.86M by Medicaid between Jan 2018 and Dec 2024, across 257 billing codes. Its largest line is 99285, emergency room visit (most serious) — 24% of everything it billed.
33Billing provider infoLATROBE AREA HOSPITAL, INC.
LATROBE, PA 15650
LATROBE, PA 15650
33aNPI1821015462assigned 07/17/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.86M
24GClaims200,700
24DCodes billed257
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#60 of 154
Median peer was paid$2.82M
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 654 | $28K | |
| 2019 | 706 | $20K | |
| 2020 | 22,272 | $406K | |
| 2021 | 100,152 | $2.12M | |
| 2022 | 20,935 | $795K | |
| 2023 | 33,943 | $860K | |
| 2024incomplete | 22,038 | $633K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 24% | 7,633 | 7,399 | $1.15M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 6,719 | 6,492 | $713K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.0% | 5,409 | 5,297 | $388K |
| G0378 | Hospital observation service, per hour | 5.7% | 344 | 326 | $275K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.5% | 783 | 765 | $121K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.1% | 3,874 | 3,684 | $100K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 1.9% | 2,587 | 760 | $93K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.9% | 1,207 | 1,142 | $90K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.9% | 11,367 | 10,459 | $90K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 16,916 | 15,524 | $81K |
| 80053 | Comprehensive metabolic panel | 1.6% | 8,282 | 7,447 | $76K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 1.5% | 92 | 89 | $75K |
245 more codes
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.5% | 2,892 | $72K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.4% | 2,903 | $69K |
| 71271 | 1.3% | 806 | $61K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.1% | 1,706 | $55K |
| 80061 | Lipid panel | 1.0% | 3,898 | $51K |
| 80050 | General health panel | 1.0% | 1,034 | $49K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,035 | $45K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,418 | $41K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 795 | $41K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,355 | $40K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,396 | $38K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 614 | $36K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 421 | $33K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 768 | $32K |
| 80076 | <1% | 3,817 | $31K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 304 | $27K |
| 62323 | <1% | 40 | $26K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 299 | $26K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 742 | $25K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 332 | $22K |
| 71250 | <1% | 372 | $21K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 114 | $19K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,387 | $18K |
| 87480 | <1% | 766 | $18K | |
| 87660 | <1% | 751 | $17K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 307 | $16K |
| 81001 | <1% | 5,552 | $14K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 323 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,224 | $14K |
| 97161 | <1% | 404 | $14K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 230 | $14K |
| 87797 | <1% | 549 | $14K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,831 | $13K |
| 84484 | <1% | 1,614 | $13K | |
| 83690 | <1% | 2,897 | $13K | |
| 77066 | Tomosynthesis, mammo | <1% | 163 | $12K |
| 76830 | Ultrasound, transvaginal | <1% | 281 | $12K |
| 84466 | <1% | 779 | $12K | |
| 86618 | <1% | 516 | $12K | |
| 76642 | <1% | 298 | $11K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 340 | $11K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 48 | $11K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 477 | $11K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,539 | $11K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 140 | $11K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 826 | $11K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 313 | $10K |
| 88342 | <1% | 291 | $10K | |
| 82607 | <1% | 816 | $10K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 206 | $9K |
| 87428 | <1% | 490 | $9K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 420 | $9K |
| 77065 | Tomosynthesis, mammo | <1% | 183 | $9K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 831 | $9K |
| 82728 | <1% | 768 | $8K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 143 | $8K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 212 | $8K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 47 | $7K |
| 0012A | <1% | 180 | $7K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,083 | $7K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 313 | $7K |
| 93971 | <1% | 118 | $7K | |
| 90785 | <1% | 155 | $7K | |
| 76536 | <1% | 143 | $7K | |
| 83735 | <1% | 1,145 | $7K | |
| 83540 | <1% | 835 | $6K | |
| 85027 | <1% | 1,069 | $6K | |
| 86803 | <1% | 334 | $6K | |
| 84153 | <1% | 247 | $6K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 168 | $6K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 27 | $6K |
| 87481 | <1% | 210 | $6K | |
| 84702 | <1% | 322 | $5K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 292 | $5K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 967 | $5K |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 332 | $5K |
| 85730 | <1% | 907 | $5K | |
| 85610 | <1% | 1,769 | $5K | |
| 87150 | <1% | 114 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 509 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 16,915 | $5K |
| 84439 | <1% | 613 | $5K | |
| 82043 | <1% | 616 | $5K | |
| 87081 | <1% | 853 | $5K | |
| 82570 | <1% | 676 | $4K | |
| 93017 | <1% | 146 | $4K | |
| 73564 | <1% | 224 | $4K | |
| 86038 | <1% | 282 | $4K | |
| 83615 | <1% | 665 | $4K | |
| 73610 | <1% | 246 | $4K | |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | <1% | 137 | $4K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 31 | $4K |
| 97162 | <1% | 92 | $4K | |
| 82746 | <1% | 303 | $3K | |
| 87186 | <1% | 482 | $3K | |
| 97010 | <1% | 425 | $3K | |
| 86617 | <1% | 76 | $3K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 16 | $3K |
| 74019 | <1% | 237 | $3K | |
| 74018 | <1% | 251 | $3K | |
| 0011A | <1% | 172 | $3K | |
| 73630 | <1% | 333 | $3K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,679 | $3K |
| 86255 | <1% | 136 | $3K | |
| 72110 | <1% | 136 | $3K | |
| 87040 | <1% | 337 | $3K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 13 | $3K |
| 84146 | <1% | 112 | $3K | |
| 73030 | <1% | 196 | $3K | |
| 87522 | Neg quan hep c or qual rna | <1% | 64 | $2K |
| 73130 | <1% | 223 | $2K | |
| 82784 | <1% | 146 | $2K | |
| 85652 | <1% | 902 | $2K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 309 | $2K |
| 73502 | <1% | 115 | $2K | |
| 84403 | <1% | 90 | $2K | |
| 97164 | <1% | 59 | $2K | |
| 82105 | <1% | 118 | $2K | |
| 87625 | <1% | 58 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 240 | $2K |
| 93296 | <1% | 162 | $2K | |
| 0002A | <1% | 69 | $2K | |
| 87340 | <1% | 142 | $2K | |
| 76775 | <1% | 54 | $2K | |
| 72100 | <1% | 106 | $2K | |
| 87077 | <1% | 316 | $2K | |
| 86140 | <1% | 754 | $2K | |
| 86787 | <1% | 98 | $2K | |
| 85379 | <1% | 194 | $2K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 40 | $2K |
| 96376 | <1% | 556 | $2K | |
| 83880 | <1% | 81 | $2K | |
| 87510 | <1% | 156 | $2K | |
| 82565 | <1% | 271 | $2K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 26 | $1K |
| 87070 | <1% | 254 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 12 | $1K |
| 86706 | <1% | 90 | $1K | |
| 84520 | <1% | 234 | $1K | |
| 0001A | <1% | 73 | $1K | |
| 73110 | <1% | 117 | $1K | |
| 86762 | <1% | 81 | $1K | |
| 83970 | <1% | 28 | $1K | |
| 93970 | <1% | 15 | $1K | |
| 84550 | <1% | 187 | $1K | |
| 94729 | <1% | 50 | $1K | |
| 86850 | <1% | 187 | $982.82 | |
| 84436 | <1% | 126 | $969.64 | |
| 84703 | <1% | 91 | $959.63 | |
| 97165 | <1% | 73 | $933.02 | |
| 87088 | <1% | 137 | $919.24 | |
| 81025 | <1% | 384 | $914.96 | |
| 86431 | <1% | 120 | $914.18 | |
| 84100 | <1% | 192 | $909.43 | |
| 94726 | <1% | 48 | $908.36 | |
| 84481 | <1% | 40 | $871.44 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 14 | $813.44 |
| 86592 | <1% | 192 | $780.08 | |
| 83655 | <1% | 69 | $773.60 | |
| 82378 | <1% | 59 | $766.27 | |
| 70486 | <1% | 16 | $746.87 | |
| 82550 | <1% | 119 | $714.71 | |
| 82950 | <1% | 101 | $674.43 | |
| 87147 | <1% | 190 | $657.85 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 14 | $655.12 |
| 83605 | <1% | 140 | $653.28 | |
| 83516 | <1% | 131 | $608.72 | |
| 82140 | <1% | 132 | $605.80 | |
| 83001 | <1% | 31 | $589.40 | |
| 82248 | <1% | 93 | $567.87 | |
| 72050 | <1% | 24 | $545.98 | |
| 82948 | <1% | 908 | $533.57 | |
| J3490 | Unclassified drugs | <1% | 1,180 | $528.66 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 55 | $503.90 |
| 85018 | <1% | 172 | $489.80 | |
| 86235 | <1% | 13 | $469.08 | |
| 86901 | <1% | 183 | $462.17 | |
| 86900 | <1% | 184 | $455.69 | |
| 90715 | <1% | 25 | $446.24 | |
| 85014 | <1% | 159 | $443.69 | |
| 80055 | <1% | 63 | $391.20 | |
| 94060 | <1% | 50 | $361.44 | |
| 81513 | <1% | 207 | $356.60 | |
| 73562 | <1% | 26 | $345.99 | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,047 | $342.78 |
| 84402 | <1% | 12 | $314.42 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,328 | $313.54 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 17 | $281.34 |
| 82947 | <1% | 72 | $264.37 | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 16 | $262.15 |
| 82977 | <1% | 26 | $223.75 | |
| 96367 | <1% | 17 | $214.68 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 12 | $213.82 |
| A9270 | Non-covered item or service | <1% | 821 | $211.55 |
| 86800 | <1% | 12 | $208.18 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 74 | $206.25 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 31 | $204.00 |
| 71101 | <1% | 12 | $201.67 | |
| 80164 | <1% | 14 | $190.56 | |
| 73590 | <1% | 12 | $188.18 | |
| 86225 | <1% | 14 | $178.12 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,092 | $164.73 |
| 73080 | <1% | 14 | $140.25 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 149 | $132.64 |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | <1% | 189 | $125.57 |
| 87205 | <1% | 59 | $122.91 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,057 | $120.67 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13 | $110.00 |
| 84480 | <1% | 15 | $107.84 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 185 | $100.04 |
| 86376 | <1% | 13 | $98.26 | |
| 87505 | <1% | 14 | $80.64 | |
| 88304 | <1% | 103 | $80.47 | |
| 84425 | <1% | 12 | $78.96 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 121 | $78.05 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 515 | $52.68 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 102 | $47.10 |
| 84156 | <1% | 12 | $45.81 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 56 | $40.19 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 273 | $37.35 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,245 | $33.97 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 615 | $32.35 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 46 | $30.97 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 37 | $28.60 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,223 | $24.50 |
| 87075 | <1% | 17 | $24.01 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 70 | $20.89 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 177 | $17.04 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 98 | $14.63 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 144 | $10.37 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,224 | $8.15 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,029 | $5.21 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 597 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 99 | $0.00 |
| 3044F | 0% | 345 | $0.00 | |
| 3052F | 0% | 43 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 348 | $0.00 |
| 3051F | 0% | 55 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 49 | $0.00 |
| 3046F | 0% | 49 | $0.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 41 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 115 | $0.00 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 0% | 163 | $0.00 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 0% | 12 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCURRY, JEFFREY (EXECUTIVE VICE PRESIDENT CFO)
| Provider | Location | Paid |
|---|---|---|
| Westmoreland Hospital Association | Greensburg, PA | $6.79M |
| Frick Hospital | Mt Pleasant, PA | $5.60M |
| Westmoreland Regional Hospital | Greensburg, PA | $3.06M |
| Latrobe Area Hospital | Latrobe, PA | $2.96M |
| Frick Hospital | Mt Pleasant, PA | $228K |
| Westmoreland Regional Hospital | Greensburg, PA | $34K |
| Westmoreland Regional Hospital | North Huntington, PA | $1K |
| Westmoreland Regional Hospital | Greensboro, PA | $35.05 |
| Latrobe Area Hospital | Latrobe, PA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.